Bimatoprost + Timolol Maleate, Calcium Carbonate

100 µg (200 dose) Nasal Spray

25, 100 mg (IV) Injectable (vial containing lyophilised powder for infusion)

4, 8 mg Film Coated Tablet

50, 150 mg Film Coated Tablet

0.01% Ophthalmic Eye Drops

0.03 %, 3 ml Ophthalmic Eye Drops (LDPE bottle with dropper)

3.5 mg Powder for Solution for IV/SC Injection

0.2% Ophthalmic Eye Drops

200 µg, 400 µg Capsule for Inhalation

0.25 mg/ml (2 ml) 0.50 mg/ml (2 ml) Vial Containing Inhalation Susp. for Nebulisation, Single Dose

0,5 mg/2 ml 1 mg/2 ml Solution for Nebulization (single-dose vials)

320 µg/9 µg (60 dose) Aerosol (MDI) 160 µg/4.5 µg (60 & 120 dose) Aerosol (MDI) 80 µg/4.5 µg (120 dose) Aerosol (MDI)

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.